Last reviewed · How we verify
CPL500036 compound
At a glance
| Generic name | CPL500036 compound |
|---|---|
| Sponsor | Celon Pharma SA |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CPL500036 compound CI brief — competitive landscape report
- CPL500036 compound updates RSS · CI watch RSS
- Celon Pharma SA portfolio CI